The U.S. Food and Drug European Communities (EC), Canadian Health Protection Branch (HPB) and Japanese Ministry of Health and Welfare (MOHW) all require an extensive list of stringent regulations to be met before a drug or other health-related product reaches the commercial market.
The U.S. Environmental Protection Agency (EPA), EC Organization for Economic Cooperation and Development (OECD), and Japanese Ministry of Agriculture, Forestry and Fisheries (MAFF) require the same for newly developed chemicals such as pesticides, fungicides, and rodenticides. All tests are performed at extremely high costs for the organization contracting the work, whether it is the federal government or the original manufacturer of the product.
With medical problems such as AIDS, heart disease, and cancer on the rise, many leading nations are facing immense pressure to spend enormous amounts of money on the pharmacological evaluation of new organic compounds in hopes of facilitating the discovery of desperately needed pharmaceuticals and allowing them to rapidly enter the world market.
The advantage of ST&T analytical capabilities via its sister organizations, the Alpha International Testing Laboratories, lies both in its personnel and in its operating location. All members of the company's Board of Scientific Advisors are active research professors in prestigious American universities who are also leading experts in the fields of applied pharmacology and toxicology This allows cutting-edge technology to be brought to the world of business.
Alpha International Testing Labs, Inc., a company which will offer faster, more cost effective analyses of newly developed product through the use of advanced testing and monitoring technologies recently developed at leading U.S. research universities.